Tirzepatide normally suppresses appetite significantly, especially at higher doses like 5mg or above
Protocol studies Table 3 provides a summary of the participant characteristics for two prospective randomized placebo-controlled studies identified
[DOI] [PMC free article] [PubMed] [Google Scholar] 98.Zekavat O.R., Fathpour G., Haghpanah S., Dehghani S.J., Zekavat M., Shakibazad N
Metabolomics-based research may further reveal valuable biomarkers for therapy monitoring, as the reprogramming of ammonium metabolism in prostate cancer generates a range of intermediate metabolites, such as polyamines, citrate, and various amino acids, as well as key metabolic enzymes, which hold promise as indicators of therapeutic response (284)